X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
SUN PHARMACEUTICAL INDUSTRIES LIMITED Quarterly Results - Equitymaster
 
SUN PHARMACEUTICAL INDUSTRIES LIMITED  - Last 8 Quarters  (SUNP)

Here are the latest quarterly results of Sun Pharma. For more details, see the Sun Pharma financial fact sheet and Sun Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.
 Interim Results
No. of Months
Qtr. Ending
3
Mar-15
*
3
Jun-15
*
3
Sep-15
*
3
Dec-15
*
3
Mar-16
*
3
Jun-16
*
3
Sep-16
*
3
Dec-16
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m61,57167,57668,37670,82176,34282,43082,65179,127 
Other income Rs m3,8371,0541,9132,192-3501,5711,1941,222 
Turnover Rs m65,40768,63070,28973,01375,99284,00183,84580,348 
Expenses Rs m52,64749,07949,04049,13151,22953,22050,97454,595 
Gross profit Rs m5,95216,48716,70317,67222,72126,79929,14924,531 
Depreciation Rs m5,6192,4012,7112,5082,6433,1603,0383,068 
Interest Rs m1,2481,2301,4841,1708861,3465371,665 
Profit before tax Rs m2,92213,90914,42116,18618,84323,86426,76821,020 
Tax Rs m-5,9992,2683,3552,0201,7063,5274,4173,729 
Profit after tax Rs m8,92111,64111,06714,16617,13720,33722,35117,291 
Gross profit margin %9.724.424.425.029.832.535.331.0 
Effective tax rate %-205.316.323.312.59.114.816.517.7 
Net profit margin %14.517.216.220.022.424.727.021.9 
Diluted EPS Rs 3.7 4.8 4.6 5.9 7.1 8.5 9.3 7.2  
Diluted EPS (TTM) Rs 21.9 21.0 19.1 19.0 22.4 26.1 30.7 32.0  
 Subscriber Feature Our View Our View Our View   Our View Our View Our View Our View  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster



Today's Market

Global Markets Ends the Week Higher on the Back of French Election Results(RoundUp)

Financial markets received a boost earlier in the week by news that centrist Emmanuel Macron had triumphed over far-right candidate Marine Le Pen in the first round of France's presidential election.

Views on news

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

Sun Pharma: US Segment Shows Signs of Improvement (Quarterly Results Update - Detailed)

Sep 12, 2016

Sun Pharma has announced its 1QFY17 results. The company has reported 22.7% YoY growth in sales and a growth of 266% in the net profits. Here is our analysis of the results.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

More Views on News

Most Popular

We Don't Want More F&O Stocks... We Need Smaller Lot Sizes(Daily Profit Hunter)

Apr 26, 2017

Are you excited to trade in the sixteen new stocks to be introduced in the F&O segment this Friday?

Our Private Class with India's Value Investing Guru(The 5 Minute Wrapup)

Apr 19, 2017

Rohan and Kunal present you the discussions with professor Sanjay Bakshi in his virtual classroom.

HDFC Bank: The Solid Outperformer(Chart Of The Day)

Apr 22, 2017

Why HDFC Bank beat the Sensex by nearly 3 times.

In an Ocean of Corporate Defaulters, Vijay Mallya is a Small Fish(Vivek Kaul's Diary)

Apr 20, 2017

While it is important to get Mallya back to India, the government needs to show the same vigour in chasing defaulters of public sector bank loans residing in India.

4 Ways GST Will Impact The Mutual Fund Industry(Outside View)

Apr 19, 2017

PersonalFN explains how GST would impact India's mutual fund industry and investors

More

SUN PHARMA SHARE PRICE


Apr 28, 2017 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA 5-YR ANALYSIS

Detailed Financial Information With Charts

COMPARE SUN PHARMA WITH

MARKET STATS